
Valbiotis
ALVAL | PA
Overview
Corporate Details
- ISIN(s):
- FR0013254851
- LEI:
- 969500VP4JBJCF0MOP60
- Country:
- France
- Address:
- RUE PAUL VATINE, 17180 PERIGNY
- Website:
- https://www.valbiotis.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Valbiotis is a research and development company committed to scientific innovation for the prevention and management of metabolic and cardiovascular diseases. The company specializes in developing and marketing plant-based, clinically tested dietary supplements and active substances. Its core focus is on major health risk factors including prediabetes, dyslipidemia, arterial hypertension, and metabolic liver diseases. Leveraging its botanical expertise, Valbiotis creates multi-target active substances that act on multiple physiological pathways. The company's product portfolio, including the ValbiotisPRO® range, is distributed through pharmacies and is aimed at both healthcare professionals and consumers seeking scientifically validated natural health solutions.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Valbiotis.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-08-11 17:30 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 18.2 KB | |
2025-07-03 17:45 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 165.4 KB | |
2025-07-03 17:45 |
Regulatory News Service
VALBIOTIS SA: Bilan semestriel du contrat de liquidité
|
French | 359.3 KB | |
2025-07-03 17:45 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 19.3 KB | |
2025-06-26 17:40 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis announces the success of its €6.9 million rights issue …
|
English | 470.3 KB | |
2025-06-26 17:40 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis annonce le succès de son augmentation de capital de 6,9…
|
French | 419.2 KB | |
2025-06-26 17:40 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis announces the success of its 6.9 million rights issue e…
|
English | 142.5 KB | |
2025-06-06 08:00 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintai…
|
English | 579.9 KB | |
2025-06-06 08:00 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis annonce le lancement d’une augmentation de capital avec…
|
French | 511.1 KB | |
2025-06-06 08:00 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintai…
|
English | 305.6 KB | |
2025-06-02 22:48 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 131.2 KB | |
2025-06-02 22:48 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 18.1 KB | |
2025-05-22 17:40 |
Earnings Release
VALBIOTIS SA: Valbiotis to launch ValbiotisPRO® Cardio-circulation on 2 June
|
English | 235.0 KB | |
2025-05-22 17:40 |
Regulatory News Service
VALBIOTIS SA: Valbiotis commercialisera le 2 juin prochain sa solution Valbio…
|
French | 201.0 KB | |
2025-05-22 17:40 |
Regulatory News Service
VALBIOTIS SA: Valbiotis to launch ValbiotisPRO Cardio-circulation on 2 June
|
English | 27.2 KB |
Automate Your Workflow. Get a real-time feed of all Valbiotis filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Valbiotis via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2023-01-17 | N/A | Other | Other | 10,400 | 46,072.00 EUR |